Needham Upgrades ICU Medical to Buy, Announces $165 Price Target

Benzinga Newsdesk www.benzinga.com Positive 58.6%

Neg 0% Neu 0% Pos 58.6%

Needham analyst Mike Matson upgrades ICU Medical (NASDAQ:ICUI) from Hold to Buy and announces $165 price target.

Comments

No comments yet. Be the first!